drugset / Trial / NCT01141296

Fenofibrate in Combination With Ursodeoxycholic Acid (UDCA) in Primary Biliary Cirrhosis

NCT01141296

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to determine if the combination of ursodeoxycholic acid (UDCA) and fenofibrate is more effective than UDCA alone in the treatment of primary biliary cirrhosis.

Timeline

Start
2011-04
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fenofibrate Small molecule 200 mg Oral